N-(4-methoxybenzyl)-6-(pyridin-4-yl)imidazo[1,2-a]pyridine-3-carboxamide

ID: ALA4874981

PubChem CID: 164626993

Max Phase: Preclinical

Molecular Formula: C21H18N4O2

Molecular Weight: 358.40

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc(CNC(=O)c2cnc3ccc(-c4ccncc4)cn23)cc1

Standard InChI:  InChI=1S/C21H18N4O2/c1-27-18-5-2-15(3-6-18)12-24-21(26)19-13-23-20-7-4-17(14-25(19)20)16-8-10-22-11-9-16/h2-11,13-14H,12H2,1H3,(H,24,26)

Standard InChI Key:  BEPGDBKELHCPIP-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
    3.7221  -27.4040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7221  -28.2311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4359  -28.6405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4359  -26.9863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1498  -27.4040    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1498  -28.2276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9330  -28.4821    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4172  -27.8158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9331  -27.1496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0070  -26.9934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1887  -26.3630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9978  -26.1910    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6353  -25.7483    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.2534  -25.4043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0625  -25.2324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6141  -25.8493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4224  -25.6778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6788  -24.8905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1205  -24.2744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3142  -24.4491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4877  -24.7175    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.0419  -25.3315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0070  -26.1706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2929  -25.7602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5787  -26.1742    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5833  -27.0031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2981  -27.4098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  2  0
  2  3  2  0
  3  6  1  0
  5  4  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  1 10  1  0
  9 11  1  0
 11 12  1  0
 11 13  2  0
 14 12  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 18 21  1  0
 21 22  1  0
 10 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 10  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4874981

    ---

Associated Targets(Human)

CLK1 Tchem Dual specificty protein kinase CLK1 (2189 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 358.40Molecular Weight (Monoisotopic): 358.1430AlogP: 3.33#Rotatable Bonds: 5
Polar Surface Area: 68.52Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.06CX LogP: 1.75CX LogD: 1.75
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.59Np Likeness Score: -1.34

References

1. Zhang Y, Xia A, Zhang S, Lin G, Liu J, Chen P, Mu B, Jiao Y, Xu W, Chen M, Li L..  (2021)  Discovery of 3,6-disubstutited-imidazo[1,2-a]pyridine derivatives as a new class of CLK1 inhibitors.,  41  [PMID:33662541] [10.1016/j.bmcl.2021.127881]

Source